A twice-yearly injection could revolutionise HIV prevention. But who gets access raises bigger questions about public money, pharmaceutical power, drug prices and shrinking global health funding. Al Jazeera’s Mikail Malik looks at the fight over access.
Subscribe to our channel: http://bit.ly/AJSubscribe
Follow us on X : https://twitter.com/AJEnglish
Find us on Facebook: https://www.facebook.com/aljazeera
Check our website: http://www.aljazeera.com/
Check out our Instagram page: https://www.instagram.com/aljazeeraenglish/
Download AJE Mobile App: https://aje.news/AJEMobile
